skip to main content

S. 2465 (115th): Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2018


A bill to amend the Public Health Service Act to reauthorize a sickle cell disease prevention and treatment demonstration program and to provide for sickle cell disease research, surveillance, prevention, and treatment.

Sponsor and status

Tim Scott

Sponsor. Junior Senator for South Carolina. Republican.

Read Text »
Last Updated: Dec 13, 2018
Length: 3 pages
Introduced
Feb 28, 2018
115th Congress (2017–2019)
Status

Enacted — Signed by the President on Dec 18, 2018

This bill was enacted after being signed by the President on December 18, 2018.

Law
Pub.L. 115-327
Source

Position statements

What legislators are saying

Chairman Alexander: This Congress, HELP Committee Produced 18 Laws Including Landmark Opioid Legislation to Combat Nations Most Pressing Public Health Crisis
    — Sen. Lamar Alexander [R-TN, 2003-2020] on Dec 20, 2018

The Week Ahead - scheduled votes, committee action and other important notes for the week of December 10, 2018
    — Rep. David Young [R-IA3, 2015-2018] on Dec 10, 2018

Reps. Burgess and Davis Statement on Sickle Cell Bill Headed to POTUS Desk
    — Rep. Michael Burgess [R-TX26] on Dec 11, 2018

More statements at ProPublica Represent...

What stakeholders are saying

R Street Institute SpendingTracker.org estimates S. 2465 will add $123 million in new spending through 2023.

History

Feb 28, 2018
 
Introduced

Bills and resolutions are referred to committees which debate the bill before possibly sending it on to the whole chamber.

Jul 25, 2018
 
Ordered Reported

A committee has voted to issue a report to the full chamber recommending that the bill be considered further. Only about 1 in 4 bills are reported out of committee.

Oct 11, 2018
 
Passed Senate (House next)

The bill was passed in a vote in the Senate. It goes to the House next. The vote was by Voice Vote so no record of individual votes was made.

Dec 11, 2018
 
Passed House

The bill was passed by both chambers in identical form. It goes to the President next who may sign or veto the bill. The vote was by voice vote so no record of individual votes was made.

Dec 18, 2018
 
Enacted — Signed by the President

The President signed the bill and it became law.

S. 2465 (115th) was a bill in the United States Congress.

A bill must be passed by both the House and Senate in identical form and then be signed by the President to become law.

Bills numbers restart every two years. That means there are other bills with the number S. 2465. This is the one from the 115th Congress.

This bill was introduced in the 115th Congress, which met from Jan 3, 2017 to Jan 3, 2019. Legislation not passed by the end of a Congress is cleared from the books.

How to cite this information.

We recommend the following MLA-formatted citation when using the information you see here in academic work:

“S. 2465 — 115th Congress: Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of ...” www.GovTrack.us. 2018. June 16, 2021 <https://www.govtrack.us/congress/bills/115/s2465>

Where is this information from?

GovTrack automatically collects legislative information from a variety of governmental and non-governmental sources. This page is sourced primarily from Congress.gov, the official portal of the United States Congress. Congress.gov is generally updated one day after events occur, and so legislative activity shown here may be one day behind. Data via the congress project.